Acyclovir
- Product NDC
- 51407-852
- 11-digit product format
- 514070852
- Labeler code
- 51407
- Product ID
- 51407-852_235e8aee-fc79-b9bc-e063-6394a90a8e34
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Golden State Medical Supply, Inc.
- Application
- ANDA206261
- Marketing category
- ANDA
- Marketing start
- 2017-08-16
- Substance
- ACYCLOVIR
- Active strength
- 200 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X4HES1O11F | ACYCLOVIR | 59277-89-3 | ACYCLOVIR |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51407-852-01 | 51407085201 | 100 CAPSULE in 1 BOTTLE, PLASTIC (51407-852-01) | 100 capsule | 2023-11-16 | No | No | Historical |
| 51407-852-05 | 51407085205 | 500 CAPSULE in 1 BOTTLE, PLASTIC (51407-852-05) | 500 capsule | 2023-11-16 | No | No | Historical |